<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01258699</url>
  </required_header>
  <id_info>
    <org_study_id>BK-C-0701-101</org_study_id>
    <nct_id>NCT01258699</nct_id>
  </id_info>
  <brief_title>A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects</brief_title>
  <official_title>A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bukwang Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bukwang Pharmaceutical</source>
  <brief_summary>
    <textblock>
      This study is Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab
      600mg in Healthy Adult Male Subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy Adult Male</condition>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BK-C-0701 480mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BK-C-0701 320mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thioctacid HR tab 600mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiocacid HR Tab 600mg</intervention_name>
    <description>600mg for 1 day</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BK-C-0701 320mg</intervention_name>
    <description>320mg for 1 day</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BK-C-0701 480mg</intervention_name>
    <description>480mg for 1 day</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male is between 20 and 45

          -  Weight is between 50 and 90kg, and in 20% of ideal weight. Ideal
             weight(kg)=(height(cm)-100)*0.9

          -  Medical history, physical examination, ECG and laboratory test are suitable to the
             study if judged by an investigator.

          -  Patient is willing to use an effective method of contraception during the study and
             for up to 1 months after the use of study drug ceases. (Effective method=spermicide
             with condom)

          -  Subject is able to give written informed consent prior to study start and to comply
             with the study requirements.

        Exclusion Criteria:

          -  Patient received drug affected to the study within 14 days from the study initiation.

          -  Patient received drug-metbolizing enzyme inducer or inhibitor such as Barbiturates
             within 1 month from the study initiation.

          -  Subject is hypersensitive investigational drug(Thioctic acid).

          -  Patient with gastrointestinal history affected absorbing investigational drug or
             inhibiting normal gastrointestinal motility, gastrointestinal operation or
             gastrointestinal wound.

          -  Patient with renal, hepatic, bronchopulmonary, cardiovascular, gastrointestinal,
             metabolic, neurological, psychotic, oncologic, allergic disease, myocardial
             infarction, cardiac crisis, hepatitis or pancreatitis history.

          -  ECG is abnormal.

          -  Patient abused drug.

          -  Patient joined other clinical study within 3 months from the study initiation.

          -  Patient doanted whole blood within 2 months or plasma blood within 1 month from the
             first medication.

          -  HBsAg, HCV Ab or HIV Ab are positive.

          -  Patient who was not suitable to the study if judged by an investigator.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2010</study_first_submitted>
  <study_first_submitted_qc>December 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2010</study_first_posted>
  <last_update_submitted>December 10, 2010</last_update_submitted>
  <last_update_submitted_qc>December 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2010</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

